ISI Report

This article explores the intersection of social sustainability, equity, and health outcomes in the context of cancer treatment, with a focus on the emerging technology of electrocoagulation. As healthcare systems strive to address the dual challenges of providing effective cancer treatment while promoting social sustainability, innovative approaches are needed to ensure equitable access to advanced medical technologies. Electrocoagulation, a technique traditionally used in water treatment, has recently shown promise as a cost-effective and minimally invasive method for cancer treatment. This study investigates how electrocoagulation can be integrated into cancer care strategies to enhance treatment equity and contribute to social sustainability. The results indicate that electrocoagulation holds significant potential for improving access to cancer care in underserved communities, thereby advancing social sustainability and health equity. This study explores the potential of electrocoagulation technology to enhance social sustainability and health equity in cancer treatment. Electrocoagulation, a technique utilizing electric currents to induce coagulation and tissue destruction, offers a promising alternative to traditional cancer therapies by potentially reducing treatment costs and improving accessibility. By analyzing case studies and clinical data, the research highlights how integrating electrocoagulation into cancer treatment protocols can address disparities in healthcare access and outcomes. The study further examines the technology's impact on patient care, focusing on its ability to deliver effective, cost-efficient treatments while promoting equitable healthcare practices. The findings suggest that advancing electrocoagulation technology not only holds promise for more sustainable and accessible cancer care but also contributes to broader goals of social sustainability and health equity.